CClinicalTrials.gg
Active, not recruitingNCT07312968Updated Jan 6, 2026

AI4Triage - Development of an Artificial Intelligence Based Methods for the Analysis of Triage Data.

An observational study in Triage, sponsored by University of Catanzaro. Active, not recruiting at 1 site in Italy. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by University of Catanzaro · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Sex
All
01

Study summary

Artificial intelligence, and in particular Graph Neural Networks (GNNs), have shown enormous potential in the analysis of complex clinical data. Thanks to their ability to model relationships between variables, GNNs represent a significant evolution compared to traditional models, enabling better interpretation of medical information and supporting data-driven decision-making in complex contexts such as emergency medicine.

The application of GNNs to clinical triage and to the prediction of length of stay can improve clinical efficiency by optimizing resource allocation and patient management. This observational study aims to evaluate the accuracy of predictions with respect to real clinical data, contributing to the development of advanced predictive tools to support healthcare decision-making processes.

02

Conditions studied

  • Triage
03

In context

Lead sponsor

University of Catanzaro is the lead sponsor of 43 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All individuals who request access to the ER will be duly considered.

Inclusion criteria

  • all

Exclusion criteria

Exclusion Criteria:

  • Patients labelled with red codes and serious injuries.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (actual)
Target follow-up
6 Months
Patient registry
Yes

Interventions

  • OtherObservation

    there is no intervetiuons

06

What researchers measure

Primary outcomes

  1. Numbers of Undertriaged

    The investigators will measure the number of misclassifications

    Time frame: 12 monthds

  2. Undertriaged

    The investigators will measure the ability to predict undertriage

    Time frame: 12 months

07

Study locations

1 site
  • University of Catanzaro
    Catanzaro, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07312968
Lead sponsor
University of Catanzaro
Collaborators
Azienda Ospedaliera Universitaria Renato Dulbecco
Responsible party
Pietro Hiram Guzzi (Full Professor, University of Catanzaro) — Principal investigator
First posted
Dec 31, 2025
Start date
Nov 1, 2025
Primary completion
Nov 2026 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Jan 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion